Clarity Pharmaceuticals Ltd
OTC:CLRPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clarity Pharmaceuticals Ltd
OTC:CLRPF
|
AU |
|
Gallant Venture Ltd
OTC:GLVNF
|
SG |
|
K
|
KAON Media Co Ltd
KOSDAQ:078890
|
KR |
|
Metall Zug AG
OTC:MTLZF
|
CH |
|
G
|
Genomtec SA
WSE:GMT
|
PL |
|
M
|
Mehran Sugar Mills Ltd
KAR:MRNS
|
PK |
|
Taiwan Paiho Ltd
TWSE:9938
|
TW |
|
A
|
Agilyx ASA
XMUN:5NQ
|
NO |
|
Ennis Inc
NYSE:EBF
|
US |
|
E
|
Estee Lauder Companies Inc
VSE:ESLA
|
US |
Shareholder Yield
Current shareholder yield for CLRPF is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CLRPF Price
Clarity Pharmaceuticals Ltd
| Average Annual Return | 14.08% |
| Standard Deviation of Annual Returns | 84.64% |
| Max Drawdown | -86% |
| Market Capitalization | 680.7m USD |
| Shares Outstanding | 312 966 000 |
| Percentage of Shares Shorted |
N/A
|
